| Financial Year |
March 31 2023 |
| Monetary Funds |
530,759,267.39 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
260,578,333.02 |
| Accounts Receivable |
664,519,965.03 |
| Advances to Suppliers |
56,947,804.32 |
| Other Receivables |
154,626,560.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
490,816,862.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,900,000.00 |
| Other Current Assets |
225,477,890.43 |
| Total Current Assets |
2,461,462,248.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
449,776,138.29 |
| Investment Properties |
138,958,555.30 |
| Fixed Assetes |
1,967,772,770.90 |
| Under-construction Projects |
988,767,823.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
19,604,309.13 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
322,364,795.91 |
| R&D expenses |
-- |
| Goodwill |
79,517,498.18 |
| Long-Term Deferred and Prepaid Expenses |
39,860,893.22 |
| Deferred Income Tax Assets |
147,824,132.77 |
| Other Non-Current Assets |
43,545,757.62 |
| Sub-Total of Non-Current Assets |
4,385,838,134.59 |
| Total Assets |
6,847,300,382.69 |
| Short-Term Loans |
232,835,047.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
145,200.00 |
| Accounts Payable |
824,067,571.38 |
| Accounts Received In Advance |
1,265,844.85 |
| Employee Compensation Payable |
38,677,343.83 |
| Taxes Payable |
118,068,937.40 |
| Interest Payable |
-- |
| Dividend Payable |
920,528.66 |
| Other payables |
167,625,346.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
140,442,327.87 |
| Other Current Liabilities |
113,737,506.45 |
| Sub-Total of Current Liabilities |
1,649,429,329.22 |
| Long-term Loans |
2,117,317,625.17 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,902,989.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,127,123,317.43 |
| Total Liabilities |
3,776,552,646.65 |
| Paid-In Capital(Or Share Stock) |
482,115,452.00 |
| Capital Surplus |
387,752,352.35 |
| Surplus Reserve |
150,423,995.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,471,384,593.40 |
| Minority Stockholder's Interest |
574,886,055.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,495,861,680.31 |
| Owner's Equity（Stockholder's Equity） |
3,070,747,736.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,847,300,382.69 |
